{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:24:06Z","timestamp":1793521446684,"version":"4.5.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is featured by movement impairments, including tremors, bradykinesia, muscle stiffness, and imbalance. PD is also associated with many non-motor symptoms, such as cognitive impairments, dementia, and mental disorders. Previous studies identify the associations between PD progression and factors such as \u03b1-synuclein aggregation, mitochondrial dysfunction, inflammation, and cell death. The cannabinoid type-2 receptor (CB<jats:sub>2<\/jats:sub> receptor) is a transmembrane G-protein-coupled receptor and has been extensively studied as part of the endocannabinoid system. CB<jats:sub>2<\/jats:sub> receptor is recently emerged as a promising target for anti-inflammatory treatment for neurodegenerative diseases. It is reported to modulate mitochondrial function, oxidative stress, iron transport, and neuroinflammation that contribute to neuronal cell death. Additionally, CB<jats:sub>2<\/jats:sub> receptor possesses the potential to provide feedback on electrophysiological processes, offering new possibilities for PD treatment. This review summarized the mechanisms underlying PD pathogenesis. We also discussed the potential regulatory role played by CB<jats:sub>2<\/jats:sub> receptor in PD.<\/jats:p>","DOI":"10.3389\/fnagi.2023.1298166","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:15:16Z","timestamp":1704687316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Research progress on the cannabinoid type-2 receptor and Parkinson\u2019s disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaoqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e0122843","DOI":"10.1371\/journal.pone.0122843","article-title":"WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid beta1-42 effects on astrocytes in primary culture","volume":"10","author":"Aguirre-Rueda","year":"2015","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"172467","DOI":"10.1016\/j.ejphar.2019.172467","article-title":"beta-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: an in vitro and in vivo study","volume":"858","author":"al-Taee","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2007.09.107","article-title":"Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death","volume":"364","author":"Athanasiou","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s12035-015-9213-3","article-title":"Neuroprotective effect of JZL184 in MPP(+)-treated SH-SY5Y cells through CB2 receptors","volume":"53","author":"Aymerich","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB(1) cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/brain\/awz344","article-title":"Evolving concepts on bradykinesia","volume":"143","author":"Bologna","year":"2020","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/iub.46","article-title":"Brain mitochondrial dysfunction in aging","volume":"60","author":"Boveris","year":"2008","journal-title":"IUBMB Life"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00702-019-02018-8","article-title":"Evidence for the use of cannabinoids in Parkinson's disease","volume":"126","author":"Buhmann","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1124\/mol.65.4.999","article-title":"Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism","volume":"65","author":"Carrier","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson's disease: implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","article-title":"Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice","volume":"16","author":"Cheng","year":"2020","journal-title":"Autophagy"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1038\/emm.2015.100","article-title":"CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Chung","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2015.04.007","article-title":"Differential upregulation of the cannabinoid CB(2) receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease","volume":"269","author":"Concannon","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.expneurol.2016.06.014","article-title":"Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease","volume":"283","author":"Concannon","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1007\/s12035-020-02054-6","article-title":"Current aspects of the endocannabinoid system and targeted THC and CBD Phytocannabinoids as potential therapeutics for Parkinson's and Alzheimer's diseases: a review","volume":"57","author":"Cooray","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"28806","DOI":"10.1038\/srep28806","article-title":"The cannabinoid receptor 2 protects against alcoholic liver disease via a macrophage autophagy-dependent pathway","volume":"6","author":"Dena\u00ebs","year":"2016","journal-title":"Sci. Rep."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.nbd.2020.104892","article-title":"Beneficial effects of the phytocannabinoid Delta(9)-THCV in L-DOPA-induced dyskinesia in Parkinson's disease","volume":"141","author":"Espadas","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson's disease biomarkers based on alpha-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J. Neurochem."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"114230","DOI":"10.1016\/j.expneurol.2022.114230","article-title":"Loss of cannabinoid receptor 2 promotes alpha-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system","volume":"359","author":"Feng","year":"2023","journal-title":"Exp. Neurol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.mce.2008.01.001","article-title":"Role of CB2 receptors in neuroprotective effects of cannabinoids","volume":"286","author":"Fern\u00e1ndez-Ruiz","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1152\/jn.01227.2005","article-title":"Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons","volume":"96","author":"Fisyunov","year":"2006","journal-title":"J. Neurophysiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J. Neurochem."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","article-title":"Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release","volume":"91","author":"Foster","year":"2016","journal-title":"Neuron"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2014.12.003","article-title":"Identification of CB(2) receptors in human nigral neurons that degenerate in Parkinson's disease","volume":"587","author":"Garc\u00eda","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2014.01.002","article-title":"Non-motor symptoms of Parkinson's disease a review\u2026From the past","volume":"338","author":"Garcia-Ruiz","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking Neuroinflammation and neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J Immunol Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","article-title":"Alpha-synuclein aggregation and its modulation","volume":"100","author":"Ghosh","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.4081\/ejh.2017.2749","article-title":"Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study","volume":"61","author":"Giacoppo","year":"2017","journal-title":"Eur. J. Histochem."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JAD-2007-12402","article-title":"Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease","volume":"12","author":"Gr\u00fcnblatt","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: a toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","article-title":"The cannabinoid receptor: biochemical, anatomical and behavioral characterization","volume":"13","author":"Howlett","year":"1990","journal-title":"Trends Neurosci."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB(1) cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/molecules23081836","article-title":"Cannabinoid CB2 receptor gene and Environmental interaction in the development of psychiatric disorders","volume":"23","author":"Ishiguro","year":"2018","journal-title":"Molecules"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fnins.2016.00321","article-title":"Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and Neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson's disease","volume":"10","author":"Javed","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2014.10.021","article-title":"Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1","volume":"36","author":"Jia","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in brain cannabinoid CB(2) receptor research: from genes to behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e0155076","DOI":"10.1371\/journal.pone.0155076","article-title":"Activation of cannabinoid receptor 2 ameliorates DSS-induced colitis through inhibiting NLRP3 Inflammasome in macrophages","volume":"11","author":"Ke","year":"2016","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/molecules25030453","article-title":"Microglial phenotypes and their relationship to the cannabinoid system: therapeutic implications for Parkinson's disease","volume":"25","author":"Kelly","year":"2020","journal-title":"Molecules"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0135776","DOI":"10.1371\/journal.pone.0135776","article-title":"Dopaminergic toxin 1-Methyl-4-Phenylpyridinium, proteins alpha-Synuclein and glia maturation factor activate mast cells and release inflammatory mediators","volume":"10","author":"Kempuraj","year":"2015","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrendo.2014.35","article-title":"Autophagy\u2014a key player in cellular and body metabolism","volume":"10","author":"Kim","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","article-title":"Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor","volume":"139","author":"Klegeris","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms22010019","article-title":"CB2 receptor in microglia: the Guardian of self-control","volume":"22","author":"Komorowska-Muller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"CD007204","DOI":"10.1002\/14651858.CD007204.pub2","article-title":"Cannabinoids for the treatment of dementia","volume":"2009","author":"Krishnan","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1159\/000350088","article-title":"Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia\/reperfusion-induced apoptosis","volume":"31","author":"Li","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1038\/s41598-017-17796-y","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/s41467-022-31168-9","article-title":"Deficiency in endocannabinoid synthase DAGLB contributes to early onset parkinsonism and murine nigral dopaminergic neuron dysfunction","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"809965","DOI":"10.3389\/fphar.2021.809965","article-title":"Anti-inflammatory and pro-autophagy effects of the cannabinoid receptor CB2R: possibility of modulation in type 1 diabetes","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-3-540-74805-2_14","article-title":"Presynaptic modulation by endocannabinoids","volume":"184","author":"Lovinger","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-15-4272-5_2","article-title":"Autophagy and Parkinson's disease","volume":"1207","author":"Lu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","article-title":"The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis","volume":"10","author":"Maccarrone","year":"2003","journal-title":"Cell Death Differ."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"130639","DOI":"10.1155\/2015\/130639","article-title":"Anandamide, acting via CB2 receptors, alleviates LPS-induced Neuroinflammation in rat primary microglial cultures","volume":"2015","author":"Malek","year":"2015","journal-title":"Neural Plast."},{"key":"ref69","first-page":"618","article-title":"Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system","volume":"291","author":"McAllister","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"105729","DOI":"10.1016\/j.phrs.2021.105729","article-title":"The endocannabinoidome in neuropsychiatry: opportunities and potential risks","volume":"170","author":"Morris","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2015.07.024","article-title":"Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"273","author":"Mounsey","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and Monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB(1) and CB(2) receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease \u2013 successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.3892\/etm.2018.6753","article-title":"The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress","volume":"16","author":"Parlar","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ana.25864","article-title":"Non-motor symptoms in Parkinson's disease are reduced by Nabilone","volume":"88","author":"Peball","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/mdc3.13471","article-title":"Effects of Nabilone on sleep outcomes in patients with Parkinson's disease: a post-hoc analysis of NMS-nab study","volume":"9","author":"Peball","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00702-019-02021-z","article-title":"Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (the NMS-nab study)","volume":"126","author":"Peball","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obes."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41580-021-00361-x","article-title":"Author correction: mitochondrial proteins: from biogenesis to functional networks","volume":"22","author":"Pfanner","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem. Res."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nn.4660","article-title":"Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease","volume":"20","author":"Roy","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","article-title":"Autophagy in health and disease: a comprehensive review","volume":"104","author":"Saha","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00213-019-5166-y","article-title":"Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice","volume":"236","author":"Sahu","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mds.23971","article-title":"Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations","volume":"27","author":"Schneider","year":"2012","journal-title":"Mov. Disord."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1042\/BCJ20160674","article-title":"Regulation of divalent metal transporter-1 by serine phosphorylation","volume":"473","author":"Seo","year":"2016","journal-title":"Biochem. J."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/cns.12349","article-title":"Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome","volume":"20","author":"Shao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/glia.20108","article-title":"Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes","volume":"49","author":"Sheng","year":"2005","journal-title":"Glia"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"67837","DOI":"10.18632\/oncotarget.18871","article-title":"AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.2174\/1871527313666141130224206","article-title":"Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review","volume":"13","author":"Skaper","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1021\/acs.jmedchem.7b00155","article-title":"Perspectives of cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative disorders: structure-affinity relationship (SAfiR) and structure-activity relationship (SAR) studies","volume":"60","author":"Spinelli","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/can.2017.0002","article-title":"Cannabinoids in Parkinson's disease","volume":"2","author":"Stampanoni Bassi","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/glia.20084","article-title":"Cannabinoid signaling in glial cells","volume":"48","author":"Stella","year":"2004","journal-title":"Glia"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the Hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1523\/JNEUROSCI.0247-14.2014","article-title":"Presynaptic calcium channel inhibition underlies CB(1) cannabinoid receptor-mediated suppression of GABA release","volume":"34","author":"Szabo","year":"2014","journal-title":"J. Neurosci."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-019-0106-4","article-title":"Dementia in long-term Parkinson's disease patients: a multicentre retrospective study","volume":"6","author":"Szeto","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.2337\/db09-1881","article-title":"Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways","volume":"59","author":"Tedesco","year":"2010","journal-title":"Diabetes"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"421.e1","DOI":"10.1016\/j.neurobiolaging.2010.09.012","article-title":"Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine","volume":"33","author":"Ternianov","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","article-title":"Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease","volume":"231","author":"Thakur","year":"2013","journal-title":"Neuroscience"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"ref113","first-page":"56","article-title":"Cannabis use and its association with psychological disorders","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol. Bull."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2169\/internalmedicine.52.8333","article-title":"Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease","volume":"52","author":"Utsumi","year":"2013","journal-title":"Intern. Med."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/ph10030060","article-title":"Neuroprotective effects of beta-Caryophyllene against dopaminergic neuron injury in a murine model of Parkinson's disease induced by MPTP","volume":"10","author":"Viveros-Paredes","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"108843","DOI":"10.1016\/j.biopha.2019.108843","article-title":"Progress of immunotherapy of anti-alpha-synuclein in Parkinson's disease","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1007\/s11033-023-08395-4","article-title":"Cannabinoid type 2 receptor activation inhibits MPP+-induced M1 differentiation of microglia through activating PI3K\/Akt\/Nrf2 signal pathway","volume":"50","author":"Wang","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/jnnp-2017-315985","article-title":"Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases","volume":"88","author":"Warren","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.chembiol.2006.08.005","article-title":"Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake","volume":"13","author":"Wetli","year":"2006","journal-title":"Chem. Biol."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/bj3130017","article-title":"Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer","volume":"313","author":"Wiseman","year":"1996","journal-title":"Biochem. J."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1073\/pnas.0306707101","article-title":"P2X7 receptors control 2-arachidonoylglycerol production by microglial cells","volume":"101","author":"Witting","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3389\/fphar.2018.01292","article-title":"Activating cannabinoid receptor 2 protects against diabetic cardiomyopathy through autophagy induction","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41401-020-00530-2","article-title":"The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders","volume":"41","author":"Xin","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41401-018-0051-5","article-title":"Integrating endocannabinoid signaling in the regulation of anxiety and depression","volume":"40","author":"Yin","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10753-018-0945-x","article-title":"Selective activation of cannabinoid receptor 2 attenuates myocardial infarction via suppressing NLRP3 Inflammasome","volume":"42","author":"Yu","year":"2019","journal-title":"Inflammation"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.3390\/cells10123548","article-title":"The neuroprotective effects of the CB2 agonist GW842166x in the 6-OHDA mouse model of Parkinson's disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/adb.12367","article-title":"Expression of functional cannabinoid CB(2) receptor in VTA dopamine neurons in rats","volume":"22","author":"Zhang","year":"2017","journal-title":"Addict. Biol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"869797","DOI":"10.3389\/fnagi.2022.869797","article-title":"Lewy body-associated proteins A-Synuclein (a-syn) as a plasma-based biomarker for Parkinson's disease","volume":"14","author":"Zhao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.bjp.0705529","article-title":"Anandamide initiates ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells","volume":"140","author":"Zoratti","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1298166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:15:20Z","timestamp":1704687320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1298166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":135,"alternative-id":["10.3389\/fnagi.2023.1298166"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1298166","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1298166"}}